These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 15102858

  • 1. Narrow substrate specificity and sensitivity toward ligand-binding site mutations of human T-cell Leukemia virus type 1 protease.
    Kádas J, Weber IT, Bagossi P, Miklóssy G, Boross P, Oroszlan S, Tözsér J.
    J Biol Chem; 2004 Jun 25; 279(26):27148-57. PubMed ID: 15102858
    [Abstract] [Full Text] [Related]

  • 2. Bovine leukemia virus protease: comparison with human T-lymphotropic virus and human immunodeficiency virus proteases.
    Sperka T, Miklóssy G, Tie Y, Bagossi P, Zahuczky G, Boross P, Matúz K, Harrison RW, Weber IT, Tözsér J.
    J Gen Virol; 2007 Jul 25; 88(Pt 7):2052-2063. PubMed ID: 17554040
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of the substrate specificity of the human T-cell leukemia virus and human immunodeficiency virus proteinases.
    Tözsér J, Zahuczky G, Bagossi P, Louis JM, Copeland TD, Oroszlan S, Harrison RW, Weber IT.
    Eur J Biochem; 2000 Oct 25; 267(20):6287-95. PubMed ID: 11012683
    [Abstract] [Full Text] [Related]

  • 5. Analysis of substrate cleavage by recombinant protease of human T cell leukaemia virus type 1 reveals preferences and specificity of binding.
    Daenke S, Schramm HJ, Bangham CR.
    J Gen Virol; 1994 Sep 25; 75 ( Pt 9)():2233-9. PubMed ID: 8077922
    [Abstract] [Full Text] [Related]

  • 6. The protease of human T-cell leukemia virus type-1 is a potential therapeutic target.
    Tözsér J, Weber IT.
    Curr Pharm Des; 2007 Sep 25; 13(12):1285-94. PubMed ID: 17504236
    [Abstract] [Full Text] [Related]

  • 7. Substrates and inhibitors of human T-cell leukemia virus type 1 (HTLV-1) proteinase.
    Hrusková-Heidingsfeldová O, Bláha I, Urban J, Strop P, Pichová I.
    Leukemia; 1997 Apr 25; 11 Suppl 3():45-6. PubMed ID: 9209292
    [Abstract] [Full Text] [Related]

  • 8. Understanding HTLV-I protease.
    Shuker SB, Mariani VL, Herger BE, Dennison KJ.
    Chem Biol; 2003 May 25; 10(5):373-80. PubMed ID: 12770819
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Alteration of substrate and inhibitor specificity of feline immunodeficiency virus protease.
    Lin YC, Beck Z, Lee T, Le VD, Morris GM, Olson AJ, Wong CH, Elder JH.
    J Virol; 2000 May 25; 74(10):4710-20. PubMed ID: 10775609
    [Abstract] [Full Text] [Related]

  • 11. Molecular insights on analogs of HIV PR inhibitors toward HTLV-1 PR through QM/MM interactions and molecular dynamics studies: comparative structure analysis of wild and mutant HTLV-1 PR.
    Selvaraj C, Singh P, Singh SK.
    J Mol Recognit; 2014 Dec 25; 27(12):696-706. PubMed ID: 25319617
    [Abstract] [Full Text] [Related]

  • 12. Development of a microtiter plate fluorescent assay for inhibition studies on the HTLV-1 and HIV-1 proteinases.
    Bagossi P, Kádas J, Miklóssy G, Boross P, Weber IT, Tözsér J.
    J Virol Methods; 2004 Aug 25; 119(2):87-93. PubMed ID: 15158589
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system.
    Lin YC, Brik A, de Parseval A, Tam K, Torbett BE, Wong CH, Elder JH.
    J Virol; 2006 Aug 25; 80(16):7832-43. PubMed ID: 16873240
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Amino acid preferences for a critical substrate binding subsite of retroviral proteases in type 1 cleavage sites.
    Bagossi P, Sperka T, Fehér A, Kádas J, Zahuczky G, Miklóssy G, Boross P, Tözsér J.
    J Virol; 2005 Apr 25; 79(7):4213-8. PubMed ID: 15767422
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of activity of the protease from bovine leukemia virus.
    Ménard A, Leonard R, Llido S, Geoffre S, Picard P, Berteau F, Precigoux G, Hospital M, Guillemain B.
    FEBS Lett; 1994 Jun 13; 346(2-3):268-72. PubMed ID: 8013645
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.